Japanese investment and telco giant SoftBank is in talks to acquire DigitalBridge, Bloomberg reports. DigitalBridge had around $108 billion of assets under management at the end of September, ...
Drug utilization management tools can be employed to ensure that medicines are prescribed cost-effectively, but they can also be implemented in ways that reduce adherence and harm patient health. We ...
As artificial intelligence applications proliferate across healthcare, the model context protocol is an emerging industry standard that defines how AI systems, large language models and agent-based ...
NEW YORK, November 04, 2025--(BUSINESS WIRE)--Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, today announced the launch of the Houlihan Lokey Private Credit DataBank (DataBank), a ...
The Dallas-based data center provider plans to issue asset-backed securities backed by a trio of separate, fully leased facilities in Northern Virginia, Atlanta and New York, according to a presale ...
HOUSTON — Texas is quickly turning into a "data center destination". Giant tech hubs are popping up everywhere and that's fueling a historic demand for electricity especially in Houston. "It's the ...
SOUTH SAN FRANCISCO, Calif., Aug. 6, 2025 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise medication decisions, ...
The 2025 NFL draft is finally upon us, taking place this year at Lambeau Field in Green Bay, Wisconsin – Titletown – home of the Green Bay Packers, the league’s all-time winningest franchise. It's ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--First Databank, Inc. (FDB), the leading provider of drug and medical device knowledge that helps healthcare professionals make precise decisions, has been ...
The Federal Executive Council(FEC) has approved the commencement of the various activities that constitute the Nigeria Education Repository and Databank (NERD) programme sequel to the fulfilment of ...
NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that pricing ...